Published in
Wiley, Pharmacoepidemiology & Drug Safety, 3(17), p. 229-239, 2008
DOI: 10.1002/pds.1535
Links
Tools
Estimating the extent of reporting to FDA: a case study of statin-associated rhabdomyolysis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 